Modeling the ligand-receptor interaction for a series of inhibitors of the capsid protein of enterovirus 71 using several three-dimensional quantitative structure-activity relationship techniques

Journal of Medicinal Chemistry

Volumn 49, Issue 15, 2006, Pages 4517-4525

  Ke, Yi Yu ^a   Lin, Thy Hou ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CAPSID PROTEIN; DISOXARIL; LIGAND; PROTEIN INHIBITOR; RECEPTOR; SCH 48973; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; COMPUTER PROGRAM; DRUG POTENCY; DRUG SCREENING; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; IC 50; LIGAND BINDING; MODEL; MOLECULAR DYNAMICS; PROTEIN STRUCTURE; RECEPTOR BINDING; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING;

BINDING SITES; CAPSID PROTEINS; ENTEROVIRUS; LIGANDS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33746716817     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0511886     Document Type: Article

References (35)

1. Ho, M.; Chen, E. R.; Hsu, K. H.; Twu, S. J.; Chen, K. T.; Tsai, S. F.; Wang, J. R.; Shih, S. R. (Taiwan Enterovirus Epidemic Working Group) An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 1999, 341, 929-935.
2. Rueckert, R. R. Picornaviruses and their replication. Virology; Lippincott-Raven: New York, 1990; p 507.
3. Dimmock, N. J.; Easton, A. J.; Leppard, K. N. The structure of virus. Introduction to Modern Virology; 5th ed.; Blackwell Science: Oxford, 2001; pp 34-36.
4. Hogle, J. M.; Chow, M.; Filman, D. J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 1985, 229, 1358-1365.
5. Reisdorph, N.; Thomas, J. J.; Katpally, U.; Chase, E.; Harris, K.; Siuzdak, G.; Smith, T. J. Human rhinovirus capsid dynamics is controlled by canyon flexibility. Virology 2003, 314, 34-44.
6. Filman, D. J.; Syed, R.; Chow, M.; Macadam, A. J.; Minor, P. D.; Hogle, J. M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989, 8, 1567-1579.
7. Lewis, J. K.; Bothner, B.; Smith, T. J.; Siuzdak, G. Antiviral agent blocks breathing of the common cold virus. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6774-6778.
8. Smith, T. J.; Kremer, M. J.; Luo, M.; Vriend, G.; Arnold, E.; Kamer, G.; Rossmann, M. G.; McKinlay, M. A.; Diana, G. D.; Otto, M. J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 1986, 233, 1286-1293.
9. Pevear, D. C.; Tull, T. M.; Seipel, M. E.; Groarke, J. M. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 1999, 43, 2109-2115.
10. Kaiser, L.; Crump, C. E.; Hayden, F. G. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Res. 2000, 47, 215-220.
11. Patick, A. K.; Binford, S. L.; Brothers, M. A.; Jackson, R. L.; Ford, C. E.; Diem, M. D.; Maldonado, F.; Dragovich, P. S.; Zhou, R.; Prins, T. J.; Fuhrman, S. A.; Meador, J. W.; Zalman, L. S.; Matthews, D. A.; Worland, S. T. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 1999, 43, 2444-2450.
12. Romero, J. R. Pleconaril: A novel antipicornaviral drug. Expert Opin. Investig. Drugs 2001, 10, 369-379.
13. McKinlay, M. A.; Pevear, D. C.; Rossmann, M. G. Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Annu. Rev. Microbiol. 1992, 46, 635-654.
14. Shia, K. S.; Li, W. T.; Chang, C. M.; Hsu, M. C.; Chern, J. H.; Leong, M. K.; Tseng, S. N.; Lee, C. C.; Lee, Y. C.; Chen, S. J.; Peng, K. C.; Tseng, H. Y.; Chang, Y. L.; Tai, C. L.; Shih, S. R. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors. J. Med. Chem. 2002, 45, 1644-1655.
15. Hendry, E.; Hatanaka, H.; Fry, E.; Smyth, M.; Tate, J.; Stanway, G.; Santti, J.; Maaronen, M.; Hyypia, T.; Stuart, D. The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses. Structure Fold Des. 1999, 7, 1527-1538.
16. InsightlI Homology Model; Version 2000 ed.; Accelrys Inc.: San Diego, CA.
17. Cramer, R. D., 3rd; Patterson, D. E.; Bunce, J. D. Recent advances in comparative molecular field analysis (CoMFA). Prog. Clin. Biol. Res. 1989, 291, 161-165.
18. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4146.
19. CATALYST, version 4.9; Accelrys Inc. (previously known as Molecular Simulations, Inc.): San Diego, CA.
20. Cruciani, G.; Pastor, M.; Guba, W. VolSurf: A new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. 2000, 11 Suppl 2, S29-39.
21. Ewing, T. J.; Makino, S.; Skillman, A. G.; Kuntz, I. D. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 2001, 15, 411-428.
22. GLUE, version 1.0; Molecular Discovery Ltd: Perugia, Italy.
23. Chern, J. H.; Lee, C. C.; Chang, C. S.; Lee, Y. C.; Tai, C. L.; Lin, Y. T.; Shia, K. S.; Lee, C. Y.; Shih, S. R. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones. Bioorg. Med. Chem. Lett. 2004, 14, 5051-5056.
24. Shih, S. R.; Ho, M. S.; Lin, K. H.; Wu, S. L.; Chen, Y. T.; Wu, C. N.; Lin, T. Y.; Chang, L. Y.; Tsao, K. C.; Ning, H. C.; Chang, P. Y.; Jung, S. M.; Hsueh, C.; Chang, K. S. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res. 2000, 68, 127-136.
25. Lentz, K. N.; Smith, A. D.; Geisler, S. C.; Cox, S.; Buontempo, P.; Skelton, A.; DeMartino, J.; Rozhon, E.; Schwartz, J.; Girijavallabhan, V.; O'Connell, J.; Arnold, E. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: Comparison of the structural and biological properties of three poliovirus serotypes. Structure 1997, 5, 961-978.
26. Hiremath, C. N. Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: Structural comparison with drug binding in rhinovirus 14. Acta Crystallogr. D Biol. Crystallogr. 1995, 51, 473-489.
27. Weiner, S. J.; Kollman, P. A.; Nguyen, D. T.; Case, D. A. An all atom force field for simulations of proteins and nucleic acids. J. Comput. Chem. 1986, 7, 230-252.
28. SYBYL; Version 6.9.1 ed.; Tripos Associates, Inc.; St. Louis, MO.
29. Wang, J.; Cieplak, P.; Kollman, P. A. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules. J. Comput. Chem. 2000, 21, 1049-1074.
30. Dunn, W. J.; Wold, S.; Edelund, U.; Helberg, S. Multivariate Structure-Activity Relationships between Data from a Battery of Biological Tests and an Ensemble of Structure Descriptors: The PLS Methodology. Quant. Struct.-Act. Relat. 1984, 3, 131-137.
31. Xue, C. X.; Cui, S. Y.; Liu, M. C.; Hu, Z. D.; Fan, B. T. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA. Eur. J. Med. Chem. 2004, 39, 745-753.
32. Pastor, M.; Cruciani, G.; Clementi, S. Smart region definition: A new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships. J. Med. Chem. 1997, 40, 1455-1464.
33. Sutler, J.; Guner, O. F.; Hoffman, R.; Li, H.; Waldman, M. Effect of Variable Weight and Tolerances on Predictive Model Generation. In Pharmacophore Perception, Development, and Use in Drug Design; Guner, O. F., Ed.; International University Line: La Jolla, CA, 1999, pp 501-511.
34. Colovos, C.; Yeates, T. O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 1993, 2, 1511-1519.
35. Shih, S. R.; Tsai, M. C.; Tseng, S. N.; Won, K. F.; Shia, K. S.; Li, W. T.; Chern, J. H.; Chen, G. W.; Lee, C. C.; Lee, Y. C.; Peng, K. C.; Chao, Y. S. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother 2004, 48, 3523-3529.